×
Amphastar Pharmaceuticals EBIT 2012-2024 | AMPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Amphastar Pharmaceuticals ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Amphastar Pharmaceuticals EBIT 2012-2024 | AMPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Amphastar Pharmaceuticals ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.9B
BridgeBio Pharma (BBIO)
$4.4B
Bausch Health Cos (BHC)
$2.9B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$506M
Personalis (PSNL)
$245M
Assembly Biosciences (ASMB)
$96M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$6M
Teligent (TLGT)
$0M